Low valuations and accelerating innovation are helping biotech recover from one of its worst drawdowns on record.
Insights
Our latest thinking on the themes shaping today’s investment landscape. Explore timely updates, quarterly features and in-depth analysis straight from our experts.
In light of recent developments in the U.S. presidential campaign, signals embedded in options markets now indicate nearly even odds between President Biden and former President Trump.
The French parliamentary elections are a potential risk event for European equities, but what did the results of the first round of voting tell us?
In their mid-year outlook, the PCS Team at Janus Henderson discusses how pricing disparities between U.S. securitized and corporate bonds are creating opportunities for investors.
Generative AI is set to radically alter how humans interact with technology, likely ushering in an era of rising productivity.
These medical advances are revolutionizing patient care and creating new growth opportunities in the sector.
Considering how the U.S. election may influence markets leading up to November and which policies are worth monitoring.
The French President’s surprise calling of a snap election in response to a stronger showing from the far right in the European election has driven volatility in French bonds. Hear from Janus Henderson’s credit team on whether this represents an opportunity or risk.
The building blocks are moving into place for European mid-caps to come back into focus.
In their mid-year outlook, Marc Pinto and Lucas Klein explain why they see a growing opportunity set in stocks.
With inflation once again showing signs of easing, the Fed appears on track to cut policy rates – just not yet.